MetaCap

Elevance Health (ELV) vs Humana (HUM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Humana (HUM) has outperformed Elevance Health (ELV) over the past year, gaining 71.7% versus a gain of 22.6%. Over five years, ELV leads with a -5.1% price change compared with -9.0% for HUM. Elevance Health is the larger company by market cap ($85.23 billion vs $46.84 billion), about 1.8 times the size.

On valuation, Elevance Health trades at a lower forward P/E (13.0x vs 21.1x for Humana). Elevance Health offers the higher dividend yield (1.74% vs 0.91%). Elevance Health converts more of its revenue into profit, with a net margin of 2.8% versus 0.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ELV+22.61%HUM+71.73%
+110%+38%-34%
Nov 21, 20251 yearNov 20, 2026
ELV-4.99%HUM-10.32%
+39%-14%-67%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ELV versus HUM key metrics
MetricELVHUM
Share price$394.48$390.00
Market cap$85.23B$46.84B
1-day change+1.11%+2.63%
YTD return+12.53%+52.27%
1-year return+22.61%+71.73%
5-year return-5.06%-8.98%
P/E ratio (TTM)16.7538.05
Forward P/E13.0221.06
EPS (TTM)$23.55$10.25
Dividend yield1.74%0.91%
Annual dividend$6.87$3.54
Revenue (latest FY)$199.13B$129.66B
Revenue growth (YoY)+12.49%+10.11%
Net income (latest FY)$5.66B$1.19B
Gross margin89.36%—
Operating margin3.62%2.09%
Net margin2.84%0.92%
52-week high$450.69$462.87
52-week low$274.84$163.11
Distance from 52-week high-12.47%-15.74%
Analyst consensusbuybuy
Avg. price target upside+22.28%+30.98%
Average volume1.31M1.46M
Shares outstanding216.06M120.10M
Employees96,12967,060
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HUM has outperformed ELV by 49.1 percentage points over the past year.
  • Humana trades at a higher earnings multiple (38.0x vs 16.8x trailing P/E).

About Elevance Health

ELV stock →

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.

Health Care · Medical Specialities · 96,129 employees

About Humana

HUM stock →

Humana Inc. provides medical and specialty insurance products in the United States.

Health Care · Medical Specialities · 67,060 employees

ELV vs HUM FAQ

Which is bigger, Elevance Health or Humana?

Elevance Health (ELV) is larger, with a market capitalization of $85.23B compared with $46.84B for Humana (HUM).

Which stock has performed better over the past year, ELV or HUM?

HUM returned +71.73% over the past 12 months, compared with +22.61% for ELV (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ELV or HUM?

ELV has the lower trailing P/E at 16.8, versus 38.0 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, Elevance Health or Humana?

Elevance Health has the higher yield at 1.74%, compared with 0.91% for Humana.

Are Elevance Health and Humana in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons